The Network Advantage: defining and recognizing quality in clinical research

Join us as we present the findings of AMRC’s 2025 industry consultation on quality in clinical research and outline the steps the association will take to define and recognise quality in practice.

The Network Advantage: A Regulatory Perspective on Clinical Research Innovation with the FDA’s David Burrow 

While he’s a firm believer in the entire clinical trial process, for Carlos Orantes, Chief Executive Officer at Alcanza Clinical Research, there’s an unmistakable ‘magic’ to be found in late-stage trials. “You’re that much closer to bringing lifesaving and enhancing drugs and devices to patients by collaborating with other dedicated professionals,” he says. 

“We’re Not Giving Up Control, We’re Just Sharing it” Highlights from AMRC’s Latest Webinar on Sponsor Pain Points

The Association of Multisite Research Corporations (AMRC), the leading trade association representing multisite clinical research corporations (MCRCs), announces Jennifer Byrne, CEO of Javara, as its newest member of the Board of Directors.